Clinical study of the endoscopic pancreatic stent in patients with chronic pancreatitis

Tsuyoshi Furukawa; Kazuhiko Oohashi; Yasuo Naitoh; Yoshiki Hirooka; Youichi Ooshima; Shinichi Kanamori; Masanori Kuroiwa; Akihiro Itoh; Tomoyuki Taki; Hidemi Goto; Tetsuya Hayakawa

Clinical study of the endoscopic pancreatic stent in patients with chronic pancreatitis

Tsuyoshi Furukawa, Kazuhiko Oohashi, Yasuo Naitoh, Yoshiki Hirooka, Youichi Ooshima, Shinichi Kanamori, Masanori Kuroiwa, Akihiro Itoh, Tomoyuki Taki, Hidemi Goto, Tetsuya Hayakawa

Gastroenterology

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

We reported clinical benifits of endoscopic pancreatic stent, using 11 patients with chronic pancreatitis. All the subjects had abdominal and/or back pain and had stenosis of main pancreatic duct (MPD) in head of pancreas. We inserted stent into MPD via major papilla in 7 cases and via minor papilla in 4 cases. The diameter of used stent were 7, 8.5 and 11.5 Fr respectively. Average follow-up term after stenting are 11.7 months. Clinical symptoms were improved in all cases. Result of the exocrine function test was improved particular in 2 cases with the decreased diameter of the MPD more than 4 mm after stenting. Pancreatic endocrine function showed no change in all cases. Stent was patent in all cases for the following term. In conclusion, the pancreatic stent in patients with chronic pancreatitis showing stenosis of MPD are expected to improve clinical symptoms and to be safe endoscopic therapy.

Original language	English
Pages (from-to)	1148-1154
Number of pages	7
Journal	GASTROENTEROLOGICAL ENDOSCOPY
Volume	38
Issue number	5
Publication status	Published - 1996

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging
Gastroenterology

Cite this

@article{246adb1504714466ac0ef59b2381ab60,

title = "Clinical study of the endoscopic pancreatic stent in patients with chronic pancreatitis",

abstract = "We reported clinical benifits of endoscopic pancreatic stent, using 11 patients with chronic pancreatitis. All the subjects had abdominal and/or back pain and had stenosis of main pancreatic duct (MPD) in head of pancreas. We inserted stent into MPD via major papilla in 7 cases and via minor papilla in 4 cases. The diameter of used stent were 7, 8.5 and 11.5 Fr respectively. Average follow-up term after stenting are 11.7 months. Clinical symptoms were improved in all cases. Result of the exocrine function test was improved particular in 2 cases with the decreased diameter of the MPD more than 4 mm after stenting. Pancreatic endocrine function showed no change in all cases. Stent was patent in all cases for the following term. In conclusion, the pancreatic stent in patients with chronic pancreatitis showing stenosis of MPD are expected to improve clinical symptoms and to be safe endoscopic therapy.",

author = "Tsuyoshi Furukawa and Kazuhiko Oohashi and Yasuo Naitoh and Yoshiki Hirooka and Youichi Ooshima and Shinichi Kanamori and Masanori Kuroiwa and Akihiro Itoh and Tomoyuki Taki and Hidemi Goto and Tetsuya Hayakawa",

year = "1996",

language = "English",

volume = "38",

pages = "1148--1154",

journal = "Gastroenterological Endoscopy",

issn = "0387-1207",

publisher = "Japan Gastroenterological Endoscopy Society",

number = "5",

}

TY - JOUR

T1 - Clinical study of the endoscopic pancreatic stent in patients with chronic pancreatitis

AU - Furukawa, Tsuyoshi

AU - Oohashi, Kazuhiko

AU - Naitoh, Yasuo

AU - Hirooka, Yoshiki

AU - Ooshima, Youichi

AU - Kanamori, Shinichi

AU - Kuroiwa, Masanori

AU - Itoh, Akihiro

AU - Taki, Tomoyuki

AU - Goto, Hidemi

AU - Hayakawa, Tetsuya

PY - 1996

Y1 - 1996

N2 - We reported clinical benifits of endoscopic pancreatic stent, using 11 patients with chronic pancreatitis. All the subjects had abdominal and/or back pain and had stenosis of main pancreatic duct (MPD) in head of pancreas. We inserted stent into MPD via major papilla in 7 cases and via minor papilla in 4 cases. The diameter of used stent were 7, 8.5 and 11.5 Fr respectively. Average follow-up term after stenting are 11.7 months. Clinical symptoms were improved in all cases. Result of the exocrine function test was improved particular in 2 cases with the decreased diameter of the MPD more than 4 mm after stenting. Pancreatic endocrine function showed no change in all cases. Stent was patent in all cases for the following term. In conclusion, the pancreatic stent in patients with chronic pancreatitis showing stenosis of MPD are expected to improve clinical symptoms and to be safe endoscopic therapy.

AB - We reported clinical benifits of endoscopic pancreatic stent, using 11 patients with chronic pancreatitis. All the subjects had abdominal and/or back pain and had stenosis of main pancreatic duct (MPD) in head of pancreas. We inserted stent into MPD via major papilla in 7 cases and via minor papilla in 4 cases. The diameter of used stent were 7, 8.5 and 11.5 Fr respectively. Average follow-up term after stenting are 11.7 months. Clinical symptoms were improved in all cases. Result of the exocrine function test was improved particular in 2 cases with the decreased diameter of the MPD more than 4 mm after stenting. Pancreatic endocrine function showed no change in all cases. Stent was patent in all cases for the following term. In conclusion, the pancreatic stent in patients with chronic pancreatitis showing stenosis of MPD are expected to improve clinical symptoms and to be safe endoscopic therapy.

UR - http://www.scopus.com/inward/record.url?scp=0345764446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345764446&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0345764446

SN - 0387-1207

VL - 38

SP - 1148

EP - 1154

JO - Gastroenterological Endoscopy

JF - Gastroenterological Endoscopy

IS - 5

ER -

Clinical study of the endoscopic pancreatic stent in patients with chronic pancreatitis

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this